Mesa Laboratories, Inc. Stock price
Equities
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.2 USD | +4.80% | +2.68% | +2.37% |
Feb. 05 | Earnings Flash (MLAB) MESA LABORATORIES Posts Q3 Revenue $53.5M | MT |
Feb. 05 | Earnings Flash (MLAB) MESA LABORATORIES Reports Q3 EPS $2.02 | MT |
Financials (USD)
Sales 2024 * | 213M | Sales 2025 * | 235M | Capitalization | 579M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 2M | EV / Sales 2024 * | 2.72 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.47 x |
P/E ratio 2024 * |
-1,950
x | P/E ratio 2025 * |
286
x | Employees | 698 |
Yield 2024 * |
0.6% | Yield 2025 * |
0.6% | Free-Float | 94.26% |
1 day | +4.80% | ||
1 week | +2.68% | ||
Current month | -1.78% | ||
1 month | -0.45% | ||
3 months | +3.31% | ||
6 months | +0.33% | ||
Current year | +2.37% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Owens
CEO | Chief Executive Officer | 56 | 17-03-19 |
John Sullivan
CHM | Chairman | 71 | 04-09-30 |
John Sakys
DFI | Director of Finance/CFO | 55 | 12-10-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Sullivan
CHM | Chairman | 71 | 04-09-30 |
Mark Capone
BRD | Director/Board Member | 61 | Jan. 04 |
R. Tripeny
BRD | Director/Board Member | 65 | 22-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 107.2 | +4.80% | 21,490 |
24-03-26 | 102.3 | +2.46% | 42,616 |
24-03-25 | 99.88 | -3.04% | 25,382 |
24-03-22 | 103 | -3.30% | 23,324 |
24-03-21 | 106.5 | +1.99% | 60,632 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.37% | 579M | |
+3.10% | 197B | |
+1.11% | 71.22B | |
+12.40% | 53.77B | |
+19.12% | 48.75B | |
+6.87% | 44.22B | |
+11.92% | 28.85B | |
+9.65% | 27.62B | |
+10.13% | 28.57B | |
+19.96% | 26.73B |